Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Zentalis Pharma Q3 EPS $(0.79) Vs $(0.96) Prior Year

Author: Benzinga Newsdesk | November 06, 2023 08:22am

Zentalis Pharma (NASDAQ:ZNTL) reported quarterly losses of $(0.79) per share. This is a 17.71 percent increase over losses of $(0.96) per share from the same period last year.

Posted In: ZNTL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist